Allergy

Oncology·MeSH: Hypersensitivity

15 drugs in development·9 companies·4 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
miglustat	ANI PHARMACEUTICALS INC (ANIP)
Ocular Immunoglobulin E (IgE)	AXIM BIOTECHNOLOGIES, INC. (AXIM)

Phase 3(6)

Phase 2(5)

Drug	Company
AR101	REGENERON PHARMACEUTICALS, INC. (REGN)
ar201	Aimmune Therapeutics, Inc. (AIMT)
Dupilumab	REGENERON PHARMACEUTICALS, INC. (REGN)
intranasal epinephrine technology product candidates	ARS Pharmaceuticals, Inc. (SPRY)
rpt904	RAPT Therapeutics, Inc. (RAPT)

Preclinical(1)

Drug	Company
birch pollen allergy immunotherapy	MYMETICS CORP (MYMX)

BLA Filed(1)

Drug	Company
ar101	Aimmune Therapeutics, Inc. (AIMT)

BioSniper tracks 15 drugs in development for Allergy across 9 companies.

There are 4 clinical trials targeting Allergy tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.